top of page

NWSF NEWS.png

| NWSF Newsletter

Please find our monthly newsletters for the latest news in sarcoma advancement, foundation updates, local events, and more.

April 2026

Advancements in sarcoma.

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST).
You can learn more about biomarkers with GIST from our Researchers Update Night with Dr. Limin Zhu from Oregon Health and Science University.
Ewings sarcoma has some new treatments coming down the line. Watch Dr. Shireen Ganapathi from Seattle Children’s Hospital share on history and advancements from our Researchers Update Night.
Desmoid Tumor had a new drug approved in 2025, and now there are at least two other drugs in development.
Learn more from Dr. Jeremy Sharib from Fred Hutch Cancer Center share about what’s upcoming during our Researchers Update Night.

March 2026

AI and data-driven research helping evolve for sarcoma patients. Surgical Experience & Treatment Decision Study. FDA Drug Repurposing Initiative.

Feb 2026

Sarcoma symposium program under development.

Jan 2026

2026 marks the Northwest Sarcoma Foundation's 30th Anniversary.

bottom of page